Neurotech International Limited Price Chart
Neurotech International Limited NTI.XA Financial and Trading Overview
| Neurotech International Limited stock price | 0.08 AUD |
| Previous Close | 0.04 AUD |
| Open | 0.04 AUD |
| Bid | 0.04 AUD x N/A |
| Ask | 0.04 AUD x N/A |
| Day's Range | 0.04 - 0.04 AUD |
| 52 Week Range | 0.04 - 0.13 AUD |
| Volume | 710.3K AUD |
| Avg. Volume | 126.92K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.004214 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NTI.XA Valuation Measures
| Enterprise Value | 24.87M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.8 |
| Enterprise Value/Revenue | 15.461 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Neurotech International Limited Stock Price History
| Beta (5Y Monthly) | 2.004214 |
| 52-Week Change | -29.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.13 AUD |
| 52 Week Low | 0.04 AUD |
| 50-Day Moving Average | 0.05 AUD |
| 200-Day Moving Average | 0.07 AUD |
NTI.XA Share Statistics
| Avg. Volume (3 month) | 126.92K AUD |
| Avg. Daily Volume (10-Days) | 160.01K AUD |
| Shares Outstanding | N/A |
| Float | 596.81M |
| Short Ratio | N/A |
| % Held by Insiders | 27.16% |
| % Held by Institutions | 4.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.142857:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -316.81% |
| Gross Margin | 34.11% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -53.12% |
| Return on Equity (ttm) | -89.066% |
Income Statement
| Revenue (ttm) | 1.61M AUD |
| Revenue Per Share (ttm) | 0.002 AUD |
| Quarterly Revenue Growth (yoy) | 502.50% |
| Gross Profit (ttm) | 573.57K AUD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -5088011 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.1M AUD |
| Total Cash Per Share (mrq) | 0.01 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 24.281 |
| Book Value Per Share (mrq) | 0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4061566 AUD |
| Levered Free Cash Flow (ttm) | -2112772 AUD |
Profile of Neurotech International Limited
| Country | Australia |
| State | WA |
| City | Nedlands |
| Address | 145 Stirling Highway |
| ZIP | 6009 |
| Phone | 61 8 9389 3130 |
| Website | https://www.neurotechinternational.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.
Q&A For Neurotech International Limited Stock
What is a current NTI.XA stock price?
Neurotech International Limited NTI.XA stock price today per share is 0.08 AUD.
How to purchase Neurotech International Limited stock?
You can buy NTI.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neurotech International Limited?
The stock symbol or ticker of Neurotech International Limited is NTI.XA.
How many shares does Neurotech International Limited have in circulation?
The max supply of Neurotech International Limited shares is 0.
What is Neurotech International Limited Price to Earnings Ratio (PE Ratio)?
Neurotech International Limited PE Ratio is now.
What was Neurotech International Limited earnings per share over the trailing 12 months (TTM)?
Neurotech International Limited EPS is -0.01 AUD over the trailing 12 months.